<unk>  has been noted to have affected 1-3% of the adult population and 15-20% of the children population worldwide.  In the United States, prevalence is 10.7% in children, and 7.2% in adults.<unk>  is more commonly observed in males, particularly in those with severe cases, and has a late onset.
Eczema epidemiology and demographics
Atopic dermatitis epidemiology and demographics
Acne vulgaris epidemiology and demographics
Drug allergy epidemiology and demographics
Psoriasis epidemiology and demographics
Impetigo epidemiology and demographics
Vertigo epidemiology and demographics
Acrodermatitis chronica atrophicans epidemiology and demographics